期刊文献+

鲑鱼降钙素对老年骨质疏松性椎体骨折患者骨代谢、骨折愈合及腰背痛的干预效果 被引量:6

Interventional effects of salmon calcitonin on the bone metabolism,fracture healing and low back pain in elderly patients with osteoporotic vertebral fracture
暂未订购
导出
摘要 目的:观察具有直接抑制骨吸收、调节成骨细胞的活性和数量从而促进骨生成作用的鲑鱼降钙素对老年骨质疏松性椎体骨折患者骨代谢、骨折机愈合、腰背痛疼症状的治疗效果。方法:①选择2000-06/2003-06武汉大学人民医院骨科老年骨质疏松性椎体骨折患者138例。患者均知情同意。患者被随机分为2组:对照组65例,鲑鱼降钙素组73例。②对照组患者行卧硬板床、腰背部或胸背部垫软枕,并辅以中成药口服。鲑鱼降钙素组在对照组干预措施基础上给予鲑鱼降钙素,肌注1次/d,连续1个月,同时服用钙剂600mg/d。③分别于治疗前、治疗后1个月采用放射免疫分析法测定血骨钙素、收集晨起第2次尿,尿钙采用偶氮三胂法测定、尿羟脯氨酸采用化学发光免疫分析法测定、尿肌酐测定采用碱性苦味酸法测定,并计算尿钙/尿肌酐与尿羟脯氨酸/尿肌酐。④开始治疗后4和6及8周复查脊柱X射线平片,了解骨折愈合情况。⑤患者通过在本院门诊进行复诊的方式进行随访12个月,观察骨折愈合及腰背痛情况。⑥同组用药前后比较采用配对t检验。结果:骨质疏松患者138例中有3例因肌注密钙息出现面部潮红、头痛、恶心、呕吐、皮肤瘙痒等反应,于用药后1周左右终止治疗,最终进入结果分析135例。①所选患者治疗1个月后鲑鱼降钙素组血骨钙素明显高于治疗前犤(9.43±4.75),(7.41±3.03)μg/L,P<0.01犦;尿羟脯氨酸/尿肌酐明显低于治疗前犤(2.15±0.96),(3.32±0.96)mg/mmol,P<0.01犦。②开始治疗后4~6周复查X射线平片示鲑鱼降钙素组骨折愈合率达99%,对照组愈合率为86%。对照组患者有9例于治疗8周后骨折愈合。③鲑鱼降钙素组、对照组分别有43和8例患者于治疗2周后腰背疼痛消失,分别有19和29例患者于用药后1个月腰背痛消失;对照组有13例患者在骨折愈合后1年仍有腰痛。结论:鲑鱼降钙素能抑制骨质疏松患者的骨代谢,抑制骨吸收;鲑鱼降钙素能够促进骨质疏松性椎体骨折的愈合,并能迅速改善腰背痛症状。 AIM: To observe the therapeutic effects of salmon calcitonin, which can directively inhibit bone absorption, adjust the activity and number of osteoblasts, and accelerate osteogenesis, on the bone metabolism, fracture healing and low back pain in elderly patients with osteoporotic vertebral fracture. METHODS: ①A total of 138 elderly patients with osteoporotic vertebral fracture, who were selected from the Department of Orthopaedics, Renmin Hospital of Wuhan Univemity between June 2000 and June 2003, were randomly divided into two groups: control group (n=65) and salmon caleitonin group (n=73). ② All the patients lay on the bed with a soft pillow at lower back or upper back, and assisted by oral mid-patent medicine, besides, those in the salmon calcitonin group were treated by intramuscular injection of Miacalcic, once a day for a month continuously, they also took calcium 600 mg per day. ③ Before treatment and 1 month after treatment, blood osteocalcin was determined with radioimmunoassay, the second urine after get-up in the morning was collected, urinary calcium was detected with the azo three amine method, urinary hydroxyproline with chemiluminoimmunoassay, urinary creatinine with the basic bitter acid method, and the urinary calcium/urinary creatinine ratio and urinary hydroxyproline/urinary creatinine ratio were calculated. ④ The spinogram was reexamined at 4, 6 and 8 weeks after treatment to investigate the condition of fracture healing. ⑤ The patients were followed up for 12 months by means of reexamination, the fracture healing and low back pain were observed. ⑥ The difference before and after medication in the same group was compared with the paired t test. RESULTS: Of the 138 patients with osteoporosis, 3 cases stopped the treatment at about 1 week after medication because of the occurrence of facial flush, headache, nausea, emesis and itch of skin after intramuscular injection of Miacalcic, and finally 135 cases were involved in the analysis of results. ① In the salmon calcitonin group at 1 month after treatment, the blood osteocalcin was obviously higher than that before treatment [(9.43±4.75), (7.41±3.03) μg/L, P〈 0.01], urinary hydroxyproline/urinary creatinine ratio was obviously lower than that before treatment [(2.15±0.96),(3.32±0.96) mg/mmol, P 〈 0.01]. ② The reexamination of spinogram at 4, 6 and 8 weeks after treatment indicated that the healing rate of fracture was 99% in the salmon calcitonin group and 86% in the control group. The fracture healed in 9 cases at 8 weeks after treatment in the control group. ③ The low back pain disappeared at 2 weeks after treatment in 43 cases and 8 cases respectively in the salmon calcitonin group and control group, that disappeared at 1 month after medication in 19 cases and 29 cases respectively in the salmon calcitonin group and control group. Ten cases in the control group still had lumbag at 1 year after the healing of fracture. CONCLUSION: Salmon calcitonin can inhibit the bone metabolism and bone absorption of patients with osteoporosis. Salmon calcitonin can accelerate the healing of osteoporotic vertebral fraction, and rapidly improve the symptoms of low back pain.
出处 《中国临床康复》 CSCD 北大核心 2005年第27期156-157,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献5

  • 1王维,何成奇.骨质疏松症与衰老的关系[J].中国临床康复,2005,9(7):93-95. 被引量:26
  • 2Garcia-Delgado I, Prieto S, Gil-Fraguas L, et al. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 1997;60(2): 155 -9.
  • 3Munoz-Torres M, Alonso G, Raya MP. Calcitonin therapy in osteoporosis. Treat Endocrinol 2004;3(2):117-32.
  • 4Mehta NM, Malootian A, Gilligan JP. Calcitonin for osteoporosis and bone pain.Curr Pharm Des 2003;9(32):2659-76.
  • 5Thamsborg G, Storm TL, Sykulski R, et al. Effect of different doses of nasal salmon calcitonin on bone mass.Calcif Tissue Int 1991;48(5):302-7.

二级参考文献17

  • 1吴明霞,周琳瑛,陈文列,吴炳煌,刘献祥.针灸对去卵巢大鼠骨密度、强度及超微结构的影响[J].中国临床康复,2004,8(18):3546-3547. 被引量:23
  • 2赵玉堂,刘凯军,李金花,蔡新吉,杨剑辉.骨矿含量与肾虚、肾主骨关系的研究[J].中国骨质疏松杂志,1996,2(3):19-21. 被引量:131
  • 3吴青,陶国枢,刘晓玲,牟善初.北京市区1333人双能X线骨密度测定及骨质疏松症患病情况调查[J].中国骨质疏松杂志,1995,1(1):76-80. 被引量:95
  • 4D' Ippolito G, Schiller PC, Ricordi C, et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14(7) :1115 -22.
  • 5Vlassara H, Brownlee M, Manogue KR, et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins:role in normal tissue remodeling. Science 1988,240(4858) :1546 -8.
  • 6Wallach S, Rousseau G, Martin L. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 1999; 25(5) :509 - 16.
  • 7Boonen S,Aerssens J, Dequeker J, et al. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor 1: potential implications for age-related(type Ⅱ) osteoporotic fracture occurrence. Calcif Tissue Int 1997; 61 (3): 173 - 8.
  • 8Nicolas V, Prewett A, Bettica P, et al. Age-related decreases in insulin-like growth factor-Ⅰ and transforming growth factor-beta in femoral cortical bone from both men and women:implications for bone loss with aging. J Cl in Endocrinol Metab 1994;78(5):1011 -6.
  • 9Kurland ES,Rosen CJ,Cosman F, et al. Insulin-Like Growth Factor-Ⅰ in Men with Idiopathic Osteoporosis. J Clin Endocrinol Metab 1997,82 (9): 2799 - 805.
  • 10Kelley GA, Kelley KS, Tran ZV. Resistance training and bone mineral density in women: a meta-analysis of controlled trials. Am J Phys Med Rehabil 2001; 80(1 ):65 - 77.

共引文献25

同被引文献76

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部